These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31210689)

  • 41. The role of 18F-FDG PET-CT in the detection of unknown primary malignancy: a retrospective study.
    Yaylali O; Kiraç FS; Yüksel D
    Turk J Med Sci; 2016 Feb; 46(2):474-82. PubMed ID: 27511514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
    Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J
    Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
    Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
    BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Romanato J; Menezes MR; Santos AO; Bezerra ROF; Lima MCL; Etchebehere E
    Radiol Bras; 2019; 52(1):24-32. PubMed ID: 30804612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
    Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
    World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.
    Mahajan S; Barker CA; Singh B; Pandit-Taskar N
    Nucl Med Commun; 2019 Jul; 40(7):744-751. PubMed ID: 31095044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of FDG PET/CT for the Optimization of the Management of Additional Lesions Detected on Local Staging Breast MRI.
    Jalaguier-Coudray A; Delarbre B; Brenot-Rossi I; Houvenaeghel G; Villard-Mahjoub R; Viens P; Thomassin-Naggara I
    AJR Am J Roentgenol; 2016 Apr; 206(4):891-900. PubMed ID: 27003055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple values of
    Li Y; Zhou Y; Wang Q
    Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic value of navigation-guided core needle biopsy in deep regions of the head and neck with focal FDG uptake on
    Gao Y; Wu WJ; Zheng L; Huang MW; Liu SM; Zhang JG
    J Craniomaxillofac Surg; 2020 May; 48(5):508-513. PubMed ID: 32143863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
    Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ
    Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.
    Nakajo K; Tatsumi M; Inoue A; Isohashi K; Higuchi I; Kato H; Imaizumi M; Enomoto T; Shimosegawa E; Kimura T; Hatazawa J
    Jpn J Radiol; 2010 Feb; 28(2):95-100. PubMed ID: 20182843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic performance of real-time robotic arm-assisted
    Kumar R; Mittal BR; Bhattacharya A; Singh H; Bal A; Vadi SK; Sood A; Prakash G; Singh H; Sharma A
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):838-847. PubMed ID: 30167803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
    Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
    Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
    Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 18F-FDG PET/CT-directed biopsy: does it offer incremental benefit?
    Purandare NC; Kulkarni AV; Kulkarni SS; Roy D; Agrawal A; Shah S; Rangarajan V
    Nucl Med Commun; 2013 Mar; 34(3):203-10. PubMed ID: 23353885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.